RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

Harnessing AI Intelligence to Inform Creative Strategy: A Look Into Drug-GPT’s Audience Analyzer

Understanding the nuanced perspectives of both patients and healthcare professionals (HCPs) is crucial for developing effective and empathetic communication strategies. A recent case study demonstrates how Drug-GPT’s Audience Analyzer, empowered a healthcare advertising agency to achieve just that.

Addressing Key Challenges with AI-Driven Insights

The agency faced significant challenges in uncovering fresh insights about type II inflammation from both patients and HCPs, and in tailoring their messaging to effectively resonate with these diverse audiences. The aim was to bridge the communication gap and enhance engagement with Brand X.

Objectives and Approach

The primary objective was to harness data from HCPs and patients to uncover novel insights and compare the terminology used by both groups concerning type II inflammation. This data-driven approach would inform the development of a targeted campaign for Brand X.

By utilizing Drug-GPT, the agency accessed a wealth of data from closed communities, client market research, and open-source social data. This comprehensive data vault allowed for natural language queries, enabling the agency to derive actionable intelligence and inform their creative strategy effectively.

Discovering Valuable Intelligence

The use of Drug-GPT’s Audience Analyzer revealed key differences in language and awareness between patients and HCPs. For example, while HCPs commonly used technical terms like “type II inflammation,” patients referred to their experiences with terms like “flare-ups,” “steroids,” “severe wheeziness,” and “consultant visits.” This understanding enabled the agency to develop a more patient-centric campaign, ensuring that the messaging resonated more deeply with the target audience.

Achieving Results

The result was a campaign that effectively bridged the communication gap, enhancing the impact and relevance of Brand X’s messaging. By tailoring their approach based on AI-driven insights, the agency was able to connect more authentically with both patients and HCPs.

Conclusion

This case study underscores the importance of leveraging Advanced Data Science & AI tools like Drug-GPT to inform creative strategies in healthcare marketing. By tapping into comprehensive data and uncovering nuanced insights, agencies can develop more empathetic and effective communication strategies that resonate with their audience. Drug-GPT’s Audience Analyzer proved to be an invaluable asset in this process, demonstrating the power of AI in transforming healthcare advertising.

For more information on how AI intelligence can enhance your content development, visit Talking Medicines.

To dive deeper into how Drug-GPT is revolutionizing healthcare marketing, check out more case studies here. Discover how AI can drive success in your campaigns!

Sign Up to Stay Ahead of Message Impact

Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.

Subscribe on LinkedIn

Read More

#
$